’Big Short’ investor Burry turned more bullish on second quarter

Michael Burry's Scion Asset Management significantly altered its Q1 portfolio, pivoting from prior bearish bets against Chinese tech giants to a bullish stance across diverse sectors. The firm established new call options and long positions in companies including Alibaba, JD.com, Dutch semiconductor supplier ASML Holding, and U.S. firms such as Meta Platforms and UnitedHealth Group. This strategic re-positioning occurred as the S&P 500 and Nasdaq recovered significantly, achieving double-digit gains for the quarter.

Analysis

Securities filings from the first quarter reveal a significant strategic pivot by Michael Burry's Scion Asset Management, shifting from a bearish stance on Chinese technology to a broadly bullish outlook across multiple sectors. The firm established new positions through call options in Chinese companies Alibaba and JD.com, a reversal from bets against them in the prior quarter. This renewed international conviction was complemented by new bullish bets on Dutch semiconductor supplier ASML Holding and several U.S. companies, including Meta Platforms, UnitedHealth Group, Lululemon, and Estee Lauder. Scion also took long-only stakes in companies such as Bruker Corp and Regeneron. This repositioning occurred against a backdrop of a strong market rebound, where the S&P 500 and Nasdaq posted double-digit quarterly gains of 10.57% and 17.75% respectively, recovering from an April low driven by tariff concerns. The market's recovery was fueled by expectations of easing trade tensions and potential interest rate cuts, a macro environment that Scion appears to be strategically positioning to capitalize on.

Key Decisions for Investors

• Given Scion Asset Management's notable shift, investors should re-evaluate the investment thesis for Chinese technology firms like Alibaba and JD.com, as well as key US and European names such as UnitedHealth and ASML, which are now part of Burry's bullish portfolio.
• Monitor developments in US-China trade policy and central bank interest rate decisions, as the market recovery and the rationale for these new positions appear sensitive to these macroeconomic factors.
• Consider this filing as a source for idea generation rather than a direct trading signal, as the disclosed positions reflect the portfolio at the end of the first quarter and may not represent current holdings.
• The broad-based nature of the new bullish positions across semiconductors, healthcare, and consumer goods suggests a potential tactical allocation towards sectors poised to benefit from renewed market optimism and specific fundamental drivers.